1200130-72-8 Usage
Molecular Weight
384.22 g/mol The molecular weight is the mass of one mole of the compound.
Structure
1H-Pyrrolo[2,3-b]pyridine-3-carboxylic acid, 5-broMo-2-Methyl-1-(phenylsulfonyl)The structure describes the arrangement of atoms in the molecule.
Class
Pyrrolopyridine The class represents the group of organic compounds to which the molecule belongs.
Derivative
Methyl ester The derivative indicates that the compound is a modified form of the parent compound.
Potential Applications
Medicinal chemistry and pharmaceutical research The compound has potential applications in these fields due to its interesting biological activities and its use as a building block for the synthesis of new chemical entities.
Safety Precautions
Handle with care and in accordance with safety guidelines The compound may have potential hazards and risks associated with its handling and use.
Check Digit Verification of cas no
The CAS Registry Mumber 1200130-72-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,0,1,3 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1200130-72:
(9*1)+(8*2)+(7*0)+(6*0)+(5*1)+(4*3)+(3*0)+(2*7)+(1*2)=58
58 % 10 = 8
So 1200130-72-8 is a valid CAS Registry Number.
1200130-72-8Relevant articles and documents
1, 7 - DIAZACARBAZOLES AND THEIR USE IN THE TREATMENT OF CANCER
-
, (2011/07/07)
The invention relates to 1, 7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk 1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.